← Open Payments lookup

LAURA ZITELLA: Open Payments

NPI 1265570949 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,795 in 10 payments from 8 companies in 2025. Trend: 2023 $1,164 · 2024 $698 · 2025 $2,795

Consulting: $2,250Food & beverage: $545
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.1$1,200
PFIZER INC.2$1,050
ABBVIE INC.2$136
Janssen Biotech, Inc.1$125
GENZYME CORPORATION1$109
AstraZeneca Pharmaceuticals LP1$83
Ipsen Biopharmaceuticals, Inc1$76
Adaptive Biotechnologies Corporation1$17

Products named: ELREXFIO, TECVAYLI, VENCLEXTA, SARCLISA, Onivyde, IMBRUVICA, clonoSEQ.

Industry payments across CA — which companies pay providers there.